Sanofi India Ltd

Overview

Sanofi India Ltd (Sanofi India) formerly Aventis Pharma Ltd, a subsidiary of Sanofi is a healthcare company. It manufactures and markets pharmaceutical and prescription products. The company's product portfolio includes ramilich tablets, paracetamol, codeine tablets, metformin tablets, ibuflam tablets, festal dragees and active pharmaceutical ingredients includes articaine and pentoxifylline. It offers products under the brands Lantus Allegra, Combiflam, Amaryl, Clexane, Targocid, Frisium, Cardace and Sanofi. Sanofi India provides its products for various therapeutic areas such as cardiovascular disease, thrombotic diseases, metabolic disorders, oncology, respiratory, dermatology, anti-infective diseases, orthopedic diseases, gastrointestinal disorders, and central nervous system. The company operates its manufacturing units in Goa, India. Sanofi India is headquartered in Mumbai, Maharashtra, India.
Key Stats
Address
54/A, Sir Mathuradas Vasanji Road, Saki Vihar Road, Powai, MUMBAI, India
Headquarters

India

Contact

91 22 28032000

No of Employees

2,912

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

SANOFI [NSE]

Revenue (2020)

$393 m

-10.1% (2020 vs 2019)
Net Income (2020)

$65 m

10.3% (2020 vs 2019)
Net Profit Margin

16 %

22% (2020 vs 2019)
Market Cap *

$2,585 m

EPS *

$2.8

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Sanofi India LtdAurobindo Pharma LtdStrides Pharma Science LtdHikal Ltd
Key Information
Headquarters India India India India
Headquarter City MUMBAI HYDERABAD BANGALORE NAVI MUMBAI
Headquarter State/Province - - - -
No. of Employees 2,912 19,364 2,390 1,528
Entity Type Public Public Public Public

Products & Services

Sanofi India is a provider of healthcare products. The key products of the company include the following:

Products
  • Prescription Ramilich Tablets
  • Paracetamol
  • Codeine Tablets
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Brands
  • Lantus
  • Allegra
  • Combiflam
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Plans/Strategy In April, the company announced its plans to sell a select portfolio of its over-the-counter…
2019 Contracts/Agreements In February, the company and Health Services (Government of Goa) entered into partnership to build…
2019 Divestiture In September, the company agreed to sell its manufacturing facility in Ankleshwar, Gujarat, India to…
2015 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
1956 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
28 Jul 2021 Universal Nutriscience to Acquire Nutraceuticals Business of Sanofi Asset Transaction Universal Nutriscience Private Limited Sanofi India Ltd
23 Apr 2021 Sanofi India May Sell OTC Drugs to Piramal Enterprises Asset Transaction Piramal Enterprises Ltd. Sanofi India Ltd
05 Feb 2021 Sanofi India Plans to Sell Soframycin and Sofradex Brands Asset Transaction Sanofi India Ltd
11 Sep 2019 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
24 Aug 2011 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
24 Aug 2011 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit